SCHEMBL19873479

SCHEMBL19873479

CN1CCCC1CCNc1nc(-c2cccc(C(Cl)(Cl)Cl)c2)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACP1 P24666 2/20 0.45
▸ NMT1 P30419 2/20 0.41
▸ CHRM3 P20309 2/20 0.39
▸ HRH2 P25021 2/20 0.38
▸ HRH1 P35367 2/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.38
▸ ACKR3 P25106 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ ERAP1 Q9NZ08 1/20 0.38
▸ CAMK2D Q13557 1/20 0.38
▸ RAD52 P43351 2/20 0.37
▸ SLC2A1 P11166 3/20 0.37
▸ SLC22A1 O15245 1/20 0.36
▸ MLNR O43193 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16928527 0.91 ACP1 (0.56) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL16928011 0.89 ACP1 (0.48) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL16928205 0.89 NMT1 (0.51) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL19873467 0.88 ACP1 (0.40) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL19873510 0.88 TRPV1 (0.36) ACP1CHRM3DRD2DRD3
SCHEMBL16928309 0.87 ACP1 (0.47) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL16928222 0.87 ACP1 (0.45) ACP1NMT1HRH2HRH1HRH3
SCHEMBL19873462 0.86 CAMK2D (0.48) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL16928030 0.85 CHRM3 (0.42) ACP1NMT1CHRM3HRH2HRH1
SCHEMBL16928032 0.84 CAMK2D (0.44) ACP1NMT1CHRM3HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351538-A1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS The United States of America, as represented by The Secretary of The Army, on behalf of Walter Reed Army Institute of Research (US) 2018-07-25 — — EP disclosed
EP-2970153-B1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS THE US SECRETARY OF THE ARMY ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) 2018-02-21 — — EP disclosed
Send feedback